Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INC | Financial_Report.xls |
| EX-31.1 - EX-31.1 - GALECTIN THERAPEUTICS INC | d826567dex311.htm |
| EX-31.2 - EX-31.2 - GALECTIN THERAPEUTICS INC | d826567dex312.htm |
| EX-32.2 - EX-32.2 - GALECTIN THERAPEUTICS INC | d826567dex322.htm |
| EX-32.1 - EX-32.1 - GALECTIN THERAPEUTICS INC | d826567dex321.htm |
| EX-21.1 - EX-21.1 - GALECTIN THERAPEUTICS INC | d826567dex211.htm |
| 10-K - FORM 10-K - GALECTIN THERAPEUTICS INC | d826567d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement Nos. 333-116629, 333-109893, 333-159247, 333-198070, 333-176306, and 333-176305 on Form S-8, and Registration Nos. 333-194747, 333-172849, 333-150898, 333-148911, 333-139974, 333-132459, 333-118907, 333-115118, 333-111650 and 333-109887 on Form S-3, of our reports dated March 18, 2015 relating to our audits of the consolidated financial statements and internal control over financial reporting, which appear in this Annual Report on Form 10-K of Galectin Therapeutics, Inc. for the year ended December 31, 2014.
/S/ McGladrey LLP
Charlotte, North Carolina
March 18, 2015